Thermo Fisher Scientific Continues Support for COVID-19 Testing on Historically Black College and University Campuses

- Thermo Fisher Scientific Inc., (NYSE:TMO) the world leader in serving science, today announced continuing support for The Just Project a national initiative to provide COVID-19 testing to students, faculty and staff across more than 60 historically black colleges and universities (HBCUs) at no cost. A $7.5 million commitment for the 2021-2022 school year will once again provide diagnostic instruments, test kits and related supplies.

HBCU Testing

"A year after we launched The Just Project, COVID-19 cases are increasing again, and testing is critical to ensuring campus safety," said Fred Lowery , senior vice president and president for customer channels at Thermo Fisher Scientific. "Last year HBCUs nationwide administered more than 50,000 tests under the project, and infection rates at participating schools were below 1% with minimal academic disruption. We hope other schools will join the program as we extend it through the 2021-2022 school year."

The Just Project, named after pioneering biologist Ernest Everett Just , has created a nationwide testing infrastructure with the capacity to provide free testing for all 107 HBCUs in the U.S. Currently, eight on-campus labs serve as hubs to process samples for more than 60 participating HBCUs. Testing hubs include Florida A&M University , Hampton University , Howard University College of Medicine, Meharry Medical College , Morehouse School of Medicine , Texas Southern University , Tuskegee University and Xavier University of Louisiana .

"The Just Project has made a significant difference on our campus," said Rashid Mosavin, Ph.D., dean of the College of Pharmacy and Health Sciences, Texas Southern University . "With testing available on our campus as frequently as needed, we were able to welcome our students, faculty and staff back to campus for in-person learning with confidence."

James E.K. Hildreth , M.D., Ph.D., president and CEO of Meharry Medical College said, "We're grateful for Thermo Fisher's continued support of COVID-19 testing across HBCUs to serve a broad reach of their students. Testing is the core component of a robust model in preventing the spread of infectious disease. With these resources and testing components in place, we're able to make data-driven decisions and policies to support the health and safety of our students and community."

Given the focus on recruiting diverse talent, Thermo Fisher has also committed to hiring more than 500 HBCU alumni over three years, reinforcing a commitment to create a more inclusive workplace. Since August of 2020, more than 180 HBCU alumni have joined the company.

For more information on The Just Project, please visit our website .

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $35 billion . Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 90,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com .

Media Contact Information:
Ron O'Brien
Phone: 781-622-1242
E-mail: ron.obrien@thermofisher.com

Investor Contact Information:
Rafael Tejada
Phone:  781-622-1356
E-mail: rafael.tejada@thermofisher.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/thermo-fisher-scientific-continues-support-for-covid-19-testing-on-historically-black-college-and-university-campuses-301387537.html

SOURCE Thermo Fisher Scientific

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)

Thermo Fisher Scientific Hosts 2024 Investor Day

Highlights Include the Company's Industry-Leading Businesses, Proven Growth Strategy, and Outstanding Long-Term Financial Outlook

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Cleo Diagnostics

Cleo Commences U.S. Clinical Trials

Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to confirm the commencement of U.S. clinical trials for its ovarian cancer diagnostic blood test.

Keep reading...Show less
Truscreen

TruScreen Cervical Cancer Screening Test Outperforms Traditional Pap Smear in Saudi Arabia Study

TruScreen Group Limited (NZX/ASX:TRU) is pleased to announce the preliminary publication, on 25 July 2024, of a study titled “Beyond Tradition: Investigating TruScreen’s Performance Versus Pap Smear in Cervical Cancer Detection” on Research Square1Link. The preliminary publication is subject to peer review.

Keep reading...Show less

Thermo Fisher Scientific to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Morgan Stanley 22 nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 8:30 a.m. (EDT).

You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com .

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Medtronic chairman and CEO Geoff Martha to speak at the Wells Fargo Healthcare Conference

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 .

Geoff Martha , Medtronic chairman and chief executive officer, will answer questions on the medtech industry and on the company beginning at approximately 11:55 a.m. EDT ( 12:55 p.m. CDT ).

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Cleo Diagnostics

Appendix 4E and 2024 Annual Report

Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to present its Annual Report.
Keep reading...Show less

Latest Press Releases

Related News

×